Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"

NCT06738563 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2025-12-15

No results posted yet for this study

Summary

Exclusive breastfeeding during the first six months of life and continued breastfeeding for at least 24 months constitute the optimal feeding method for infants and young children.

However, breast milk and breastfeeding can be significant pathways for the transmission of certain viruses.

The objective of this study is to examine the influence of human breast milk and its composition on viral infectivity and viral transmission of the HTLV-1 virus and arboviruses such as Zika virus, yellow fever, dengue, and tick-borne encephalitis.

Conditions

  • Breastmilk Collection

Interventions

OTHER

Collection breast milk

Collection of a milk sample taken as part of women's donation

Sponsors & Collaborators

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Virginie RIGOURD, Dr · Lactarium Ile-de-France, Necker-Enfents Malades Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-10
Primary Completion
2028-09-30
Completion
2030-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06738563 on ClinicalTrials.gov